Copyright
©The Author(s) 2015.
World J Hepatol. Dec 8, 2015; 7(28): 2781-2791
Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2781
Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2781
Name | Gene locus | Size (bp) | Dysregulation | Potential role in HCC | Ref. |
HULC | 6p24.3 | 1638 | Upregulated | Associate with HBV infection or histological grade. Associate with tumor growth | [22,29,44-50] |
H19 | 11p15.5 | 2660 | Upregulated | Suppress progression, metastasis. Promote cell proliferation | [22,29,50-57] |
TUC338 | 12q13.13 | 590 | Upregulated | Increased in liver cirrhosis. Modulate cell growth | [58] |
MALAT1 | 11q13.1 | 8708 | Upregulated | Associate with tumor metastasis, recurrence | [21,22,29,59,60] |
HOTAIR | 12q13.13 | 12649 | Upregulated | Associate with invasion and metastasis. Increases chemosensitivity | [21,22,29,61-65] |
HOTTIP | 7p15.2 | 6839 | Upregulated | Associate with tumor progression and disease outcome | [28,66-68] |
HEIH | 5q35.3 | 1665 | Upregulated | Associated with HBV-HCC. Associate with prognosis | [21,29,69] |
MDIG | 3q11.2 | 30635 | Upregulated | Associate with DNA repair and prognosis | [70] |
PVT1 | 8q24.21 | 210626 | Upregulated | Associate with HCC progression and predict recurrence | [71,72] |
Linc00974 | 17q21.31 | 4890 | Upregulated | Predict tumor growth and metastasis | [73] |
UFC1 | 1q23.3 | 5113 | Upregulated | Promote HCC cell proliferation, inhibit cell apoptosis and induce cell cycle progression | [10,12,74] |
PCNA-AS1 | 20p12.3 | 384 | Upregulated | Promote tumor growth | [75] |
UCA1 | 19p13.12 | 7375 | Upregulated | Involved in chemotherapeutic resistance. Associatewith TNM stage, metastasis and postoperative survival | [50,76] |
CCAT1 | 8q24.21 | 11887 | Upregulated | Promotes HCC progression | [77-79] |
ATB | 19q13.3 | 2895 | Upregulated | Associat with poor prognosis | [80,81] |
URHC | 2q24.2 | 192173 | Upregulated | Promote cell proliferation and inhibit apoptosis | [82] |
Name | Gene locus | Size (bp) | Dysregulation | Potential role in HCC | Ref. |
MEG3 (GTL2) | 14q32.3 | 34919 | Downregulated | Associate with methylation. Predictive biomarker for monitoring epigenetic therapy | [21,83-87] |
LncRNA-LET | 15q24.1 | 2606 | Downregulated | Reduces hepatic invasion and abdominal metastases | [88] |
PTENP1 | 9p13.3 | 3917 | Downregulated | Repress the tumorigenic properties of HCC cells | [22,89] |
SRHC | 5p15.31 | 6365 | Downregulated | Inhibit cancer proliferation | [90] |
MT1DP | 16q13 | 1255 | Downregulated | Act as a tumor suppressor. Overexpression of MT1DP decreases cell proliferation but increases apoptosis | [91] |
- Citation: Liu YR, Tang RX, Huang WT, Ren FH, He RQ, Yang LH, Luo DZ, Dang YW, Chen G. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism. World J Hepatol 2015; 7(28): 2781-2791
- URL: https://www.wjgnet.com/1948-5182/full/v7/i28/2781.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i28.2781